These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26729283)

  • 1. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.
    Eskås PA; Heimark S; Eek Mariampillai J; Larstorp AC; Fadl Elmula FE; Høieggen A
    Blood Press; 2016 Aug; 25(4):199-205. PubMed ID: 26729283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.
    Hameed MA; Tebbit L; Jacques N; Thomas M; Dasgupta I
    J Hum Hypertens; 2016 Feb; 30(2):83-9. PubMed ID: 25947275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.
    Rabbia F; Fulcheri C; Di Monaco S; Covella M; Perlo E; Pappaccogli M; Veglio F
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):341-345. PubMed ID: 27160721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antihypertensive therapy affects Ambulatory Arterial Stiffness Index.
    Berni A; Ciani E; Cecioni I; Poggesi L; Abbate R; Boddi M
    Eur J Intern Med; 2011 Feb; 22(1):93-8. PubMed ID: 21238902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    Corrêa NB; de Faria AP; Ritter AM; Sabbatini AR; Almeida A; Brunelli V; Calhoun DA; Moreno H; Modolo R
    J Am Soc Hypertens; 2016 Jun; 10(6):510-516.e1. PubMed ID: 27161936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in 3 Nonadherent Patients.
    Feyz L; Bahmany S; Daemen J; van den Meiracker AH; Koch BCP; van Gelder T; Versmissen J
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):117-120. PubMed ID: 29878936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan.
    Saito I; Nomura M; Hirose H; Kawabe H
    Clin Exp Hypertens; 2010 Jul; 32(4):210-3. PubMed ID: 20608890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Non-adherence: a Major Cause of Resistant Hypertension.
    Hamrahian SM
    Curr Cardiol Rep; 2020 Sep; 22(11):133. PubMed ID: 32910342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues.
    Mariampillai JE; Eskås PA; Heimark S; Larstorp AC; Fadl Elmula FE; Høieggen A; Nortvedt P
    Blood Press; 2017 Jun; 26(3):133-138. PubMed ID: 28078909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure treatment adherence and control through 24-hour ambulatory monitoring.
    Grezzana GB; Stein AT; Pellanda LC
    Arq Bras Cardiol; 2013 Apr; 100(4):335-61. PubMed ID: 23525269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How common is true resistant hypertension?
    Bunker J; Callister W; Chang CL; Sever PS
    J Hum Hypertens; 2011 Feb; 25(2):137-40. PubMed ID: 21124342
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug adherence in hypertension: from methodological issues to cardiovascular outcomes.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Jun; 35(6):1133-1144. PubMed ID: 28306634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medication adherence and monitoring of antihypertensive treatment].
    Eskås PA; Heimark S; Mariampillai JE; Larstorp AC; Fadl Elmula FE; Høieggen A
    Tidsskr Nor Laegeforen; 2016 Jun; 136(10):920-3. PubMed ID: 27272370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to follow-up on the recommendations of the ESH/ESC guidelines for different kinds of blood pressure measurement methods].
    Schulz EG; Battegay E; Neumann L; Schmidt-Weitmann S; Brockes C
    Praxis (Bern 1994); 2009 May; 98(10):527-33. PubMed ID: 19424948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Module 4: Enhancing adherence with antihypertensives: the role of fixed-dose combinations and home blood pressure monitoring.
    Kuritzky L
    J Fam Pract; 2012 Aug; 61(8 Suppl):S23-6, S35; quiz S33. PubMed ID: 22993739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.